Colorectal cancer liver metastases (CRC-LM) Intrahepatic cholangiocarcinoma (iCCC) Perihilar cholangiocarcinoma (phCCC) Hepatocellular carcinoma (HCC) C78.7 C22.1 C24.0 C22.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. Full eligibility and fitness to undergo liver transplantation. Full eligibility and fitness to receive effective neoadjuvant or adjuvant systemic therapy. Presence of non-resectable disease. Absence of extrahepatic disease. Approval from the interdisciplinary national tumor board. Approval from the interdisciplinary liver transplant board.
Exclusion criteria
Exclusion criteria: Disease progression under systemic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Utilization rate of donor organs that would otherwise be discarded | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival Progression-free survival, with recurrence described separately as hepatic and extrahepatic. Safety endpoint: Tumor transmission rate at one and three years. | — |
Countries
Germany
Contacts
Klinik für Allgemein-, Viszeral und Transplantationschirurgie der LMU München